CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
1060nm Diode laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03756168
NCT03756168N/ACompleted
CompareCT.gov

Clinical Evaluation of the Safety and Efficacy of a 1060 nm Diode Laser for Non-invasive Fat Reduction of the Flanks

Venus Concept·interventional·Posted Nov 28, 2018·Updated Jan 30, 2024

In Brief

A clinical study evaluating 1060nm Diode laser for Fat Atrophy. Completed, enrolled 30 participants across 2 sites.

Detailed Summary

The objective of this clinical study is to assess the safety and efficacy of using a 1060 nm diode laser for non-invasive fat reduction of the flanks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFat Atrophy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 28, 2018
Enrollment StartNov 14, 2018
Primary CompletionJul 2, 2019
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.6 years ago

Interventions

1060nm Diode laserdevice

All subjects received a single treatment with Venus Bliss' 1064 nm laser administered to the flanks Venus Bliss is a non-invasive medical aesthetic device designed for body contouring. The device contains four 1060 nm diode laser applicators which are 60x60 mm in size. It has a separate RF/PEMF applicator, but this was not used in this study. There is a belt included with the system to allow for the secure attachment of the applicators to the treatment area.